Description
PE-Labeled Human VEGF R2 / KDR Protein, His Tag (Site-specific conjugation) | KDR-HP227-200tests| Gentaur Distribution US, UK & Europe
Kinase insert domain receptor (KDR) is also known as CD309, FLK1, VEGFR, VEGFR2, and is one of the subtypes of VEGFR. VEGF receptors are receptors for vascular endothelial growth factor (VEGF). There are three main subtypes of VEGFR, numbered 1, 2 and 3. The VEGF receptors have an extracellular portion consisting of 7 immunoglobulin-like domains, a single transmembrane spanning region and an intracellular portion containing a split tyrosine-kinase domain. VEGF-A binds to VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1). VEGFR-2 appears to mediate almost all of the known cellular responses to VEGF.The function of VEGFR-1 is less well defined, although it is thought to modulate VEGFR-2 signaling. Another function of VEGFR-1 may be to act as a dummy/decoy receptor, sequestering VEGF from VEGFR-2 binding (this appears to be particularly important during vasculogenesis in the embryo). In addition, VEGFR2 is able to interact with HIV-1 extracellular Tat protein upon VEGF activation, and seems to enhance angiogenesis in Kaposi's sarcoma lesions.
Source: PE-Labeled Human VEGF R2, His Tag (KDR-HP227) is produced via site-specific conjugation of PE to Human VEGF R2, His Tag under optimal conditions with a proprietary technology. Human VEGF R2, His Tag is expressed from human 293 cells (HEK293). It contains AA Ala 20 - Glu 764 (Accession # AAI31823.1).
Format: Powder.
Tag: C-6×His.
Expression System: HEK293.
Expression Region: Ala 20 - Glu 764.
Conjugate: PE Labeled.
Molecular Weight: 85.9 kDa.
Characteristics: This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 85.9 kDa.
Purity: N/A.
Buffer: PBS, 0.5% BSA, pH7.4.
Storage Conditions: -20℃, aviod light.
Shipping Conditions: RT
